Gilead Sciences, Inc. (GILD)
59/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $161.8B
- P/E
- 17.7
- Sector Median P/E
- 25.5
- F-Score
- 9/9
- ROIC
- 5.1%
- FCF Yield
- 6.3%
GILD has a Tessera Quality Score of 59, placing it in the top 50% of the Healthcare sector. Its P/E of 17.7 is 30% below the Healthcare sector median (25.5). Piotroski F-Score is 9/9; trailing ROIC is 5.1%.
Sector Peers
- Eli Lilly and Company (LLY)Mkt Cap: $1.14T · FCF: 18.8%
- Johnson & Johnson (JNJ)Mkt Cap: $633.2B · FCF: 18.2%
- AbbVie Inc. (ABBV)Mkt Cap: $461.3B · FCF: 27.5%
- Merck & Co., Inc. (MRK)Mkt Cap: $319.9B · FCF: 21.5%
- Novartis AG (NVS)Mkt Cap: $305.1B · FCF: 29.2%